{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:08:39Z","timestamp":1745496519639,"version":"3.37.3"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Endovascular selective intra-arterial (ESIA) infusion of cellular oncotherapeutics is a rapidly evolving strategy for treating glioblastoma. Evaluation of ESIA infusion requires a unique animal model. Our goal was to create a rabbit human GBM model to test IA infusions of cellular therapies and to test its usefulness by employing clinical-grade microcatheters and infusion methods to deliver mesenchymal stem cells loaded with an oncolytic adenovirus, Delta-24-RGD (MSC-D24).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Rabbits were immunosuppressed with mycophenolate mofetil, dexamethasone, and tacrolimus. They underwent stereotactic xenoimplantation of human GBM cell lines (U87, MDA-GSC-17, and MDA-GSC-8-11) into the right frontal lobe. Tumor formation was confirmed on magnetic resonance imaging, histologic, and immunohistochemistry analysis. Selective microcatheter infusion of MSC-D24 was performed via the ipsilateral internal carotid artery to assess model utility and the efficacy and safety of this approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-five rabbits were implanted (18 with U87, 2 MDA-GSC-17, and 5 MDA-GSC-8-11). Tumors formed in 68% of rabbits (77.8% for U87, 50.0% for MDA-GSC-17, and 40.0% for MDA-GSC-8-11). On MRI, the tumors were hyperintense on T2-weighted image with variable enhancement (evidence of blood brain barrier breakdown). Histologically, tumors showed phenotypic traits of human GBM including varying levels of vascularity. ESIA infusion into the distal internal carotid artery of 2 ml of MSCs-D24 (107 cells) was safe in the model. Examination of post infusion specimens documented that MSCs-D24 homed to the implanted tumor at 24 hours.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The intracranial immunosuppressed rabbit human GBM model allows testing of ESIA infusion of novel therapeutics (eg, MSC-D24) in a clinically relevant fashion.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noad152","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:28:02Z","timestamp":1692631682000},"page":"127-136","source":"Crossref","is-referenced-by-count":5,"title":["Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-4128","authenticated-orcid":false,"given":"Peter","family":"Kan","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston , Texas , USA"},{"name":"Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-6805","authenticated-orcid":false,"given":"Visish M","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Gumin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston , Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah N","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of California Los Angeles , Los Angeles, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalis E","family":"Collins","sequence":"additional","affiliation":[{"name":"Unit for Laboratory Animal Medicine, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ledbetter","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-0640","authenticated-orcid":false,"given":"Jason","family":"Huse","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zean Aaron","family":"Evan Luna","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston , Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Robledo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston , Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viren","family":"Vasandani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston , Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Medical Branch, Galveston , Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J","family":"Shpall","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Fueyo","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candelaria","family":"Gomez-Manzano","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick F","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"issue":"2","key":"2024010518131948900_CIT0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/neurintsurg-2019-015137","article-title":"Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors","volume":"12","author":"Srinivasan","year":"2020","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"2024010518131948900_CIT0002","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1093\/neuros\/nyaa470","article-title":"Endovascular selective intra-arterial infusion of mesenchymal stem cells loaded with delta-24 in a canine model","volume":"88","author":"Srinivasan","year":"2020","journal-title":"Neurosurgery."},{"article-title":"Endovascular superselective intra-arterial infusion of mesenchymal stem cells loaded with Delta-24 in a canine model","year":"2019","author":"Srinivasan","key":"2024010518131948900_CIT0003"},{"issue":"4","key":"2024010518131948900_CIT0004","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3171\/2019.6.JNS19327","article-title":"Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells","volume":"1","author":"Srinivasan","year":"2019","journal-title":"J Neurosurg."},{"issue":"6","key":"2024010518131948900_CIT0005","first-page":"neurintsurg","article-title":"Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors","volume":"14","author":"Chen","year":"2021","journal-title":"J NeuroIntervent Surg"},{"issue":"2","key":"2024010518131948900_CIT0006","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2020.11.FOCUS20845","article-title":"Intraarterial delivery of virotherapy for glioblastoma","volume":"50","author":"Srinivasan","year":"2021","journal-title":"Neurosurg Focus."},{"issue":"9-10","key":"2024010518131948900_CIT0007","first-page":"803","article-title":"Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report","volume":"65","author":"Greenberg","year":"1981","journal-title":"Cancer Treat Rep"},{"issue":"8","key":"2024010518131948900_CIT0008","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"2024010518131948900_CIT0009","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1158\/0008-5472.CAN-12-3086","article-title":"TGF-\u03b2 mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells","volume":"73","author":"Shinojima","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"2024010518131948900_CIT0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1227\/01.NEU.0000363149.58885.2E","article-title":"Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas","volume":"66","author":"Hata","year":"2010","journal-title":"Neurosurgery."},{"issue":"5","key":"2024010518131948900_CIT0011","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev."},{"issue":"23","key":"2024010518131948900_CIT0012","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1158\/0008-5472.CAN-08-3873","article-title":"Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas","volume":"69","author":"Yong","year":"2009","journal-title":"Cancer Res."},{"issue":"11","key":"2024010518131948900_CIT0013","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.21873\/anticanres.15347","article-title":"Large animal models of glioma: current status and future prospects","volume":"41","author":"Hicks","year":"2021","journal-title":"Anticancer Res."},{"issue":"3","key":"2024010518131948900_CIT0014","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5469\/neuroint.2020.00150","article-title":"Canine model for selective and superselective cerebral intra-arterial therapy testing","volume":"15","author":"Camstra","year":"2020","journal-title":"Neurointervention"},{"issue":"5","key":"2024010518131948900_CIT0015","first-page":"326","article-title":"Complex intracranial arterial anatomy in swine is unsuitable for cerebral infarction projects","volume":"55","author":"Burbridge","year":"2004","journal-title":"Can Assoc Radiol J."},{"issue":"11","key":"2024010518131948900_CIT0016","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/neuonc\/nov041","article-title":"Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma","volume":"17","author":"Singh","year":"2015","journal-title":"Neuro Oncol"},{"issue":"2","key":"2024010518131948900_CIT0017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3171\/jns.2000.92.2.0326","article-title":"An implantable guide-screw system for brain tumor studies in small animals","volume":"92","author":"Lal","year":"2000","journal-title":"J Neurosurg."},{"issue":"1","key":"2024010518131948900_CIT0018","doi-asserted-by":"crossref","first-page":"e0169656","DOI":"10.1371\/journal.pone.0169656","article-title":"Rabbit model of human gliomas: implications for intra-arterial drug delivery","volume":"12","author":"Qin","year":"2017","journal-title":"PLoS One."},{"issue":"1","key":"2024010518131948900_CIT0019","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat Commun."},{"issue":"1","key":"2024010518131948900_CIT0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40478-019-0714-6","article-title":"Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models","volume":"7","author":"Martinez-Velez","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2024010518131948900_CIT0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fonc.2018.00061","article-title":"DNX-2401, an oncolytic virus, for the treatment of newly diagnosed diffuse intrinsic pontine gliomas: a case report","volume":"8","author":"Tejada","year":"2018","journal-title":"Front Oncol."},{"issue":"2","key":"2024010518131948900_CIT0022","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-020-03435-6","article-title":"Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going","volume":"147","author":"D\u2019Amico","year":"2020","journal-title":"J Neurooncol."},{"issue":"7","key":"2024010518131948900_CIT0023","doi-asserted-by":"crossref","first-page":"e004935","DOI":"10.1136\/jitc-2022-004935","article-title":"Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry","volume":"10","author":"Nguyen","year":"2022","journal-title":"J ImmunoTher Cancer."},{"issue":"1","key":"2024010518131948900_CIT0024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad152\/51924522\/noad152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/1\/127\/55117502\/noad152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/1\/127\/55117502\/noad152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:14:01Z","timestamp":1704478441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/1\/127\/7246688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2024,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad152","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"type":"print","value":"1522-8517"},{"type":"electronic","value":"1523-5866"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,8,21]]}}}